ストックスクリーナーアプリを入手
1.00
0.00%
0.00
アフターアワーズ：
1.10
0.10
+10.00%
Cytosorbents Corp (CTSO) 最新ニュース
CytoSorbents: Q4 Earnings Snapshot - MySA
Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Cytosorbents Crp Q4 2024 beats EPS forecast By Investing.com - Investing.com UK
Cytosorbents Corp SEC 10-K Report - TradingView
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - TradingView
Cytosorbents (CTSO) Expected to Post Improved Earnings and Reven - GuruFocus
Insights into CytoSorbents's Upcoming Earnings - Benzinga
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What t - GuruFocus.com
Cytosorbents (CTSO) Expected to Announce Quarterly Earnings on Monday - Defense World
CytoSorbents Corp (CTSO) Reports Q4 Revenue Between $9.0M and $9 - GuruFocus
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Longview News-Journal
CytoSorbents Q4 Revenue Jumps 25% Despite Earnings DelayKey Metrics Released - StockTitan
Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
CytoSorbents Stock Price, Quotes and Forecasts | NASDAQ:CTSO - Benzinga
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Yahoo Finance
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents Corp. to Host Earnings Call - ACCESS Newswire
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024 -March 04, 2025 at 04:52 pm EST - Marketscreener.com
CytoSorbents delays earnings call after VP’s passing - Investing.com India
CytoSorbents Corporation Postpones Earnings Call Following Loss of Vice President and Corporate Controller - Nasdaq
CytoSorbents delays earnings call after VP’s passing By Investing.com - Investing.com Canada
CytoSorbents Delays Earnings But Confirms 25% Growth: What's Behind The Postponement? - StockTitan
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - The AM Reporter
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Earns “Buy” Rating from D. Boral Capital - Defense World
Cytosorbents (CTSO) to Release Quarterly Earnings on Thursday - Defense World
When Will CytoSorbents Release Q4 2024 Results? Key Date for Investors - StockTitan
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Yahoo Finance
CytoSorbents secures $1.6 million from warrant exercises - Investing.com
CytoSorbents Secures $1.6M Capital InjectionWill This Fuel Their FDA Application Success? - StockTitan
Cytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short Interest - Defense World
B. Riley Securities initates Cytosorbents Corp (CTSO) rating to a Buy - Knox Daily
CTSO stock touches 52-week high at $1.6 amid robust annual growth - MSN
Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
Sargent Investment Group LLC Sells 377,384 Shares of Cytosorbents Co. (NASDAQ:CTSO) - MarketBeat
Cytosorbents (NASDAQ:CTSO) Stock Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Vanguard Group Inc's Strategic Acquisition of CytoSorbents Corp Shares - GuruFocus
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Chief Medical Officer Deliargyris Efthymios exercised 16,233 in-the-money shares at a strike of $1.00, increasing direct ownership by 4% to 403,025 units (SEC Form 4) - Quantisnow
CytoSorbents Strengthens Balance Sheet with Successful Conclusion of Rights Offering - Defense World
Cytosorbents Boosts Liquidity with Successful Rights Offering - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
1.64%
0.94%
大文字化:
|
ボリューム (24 時間):